(ERA) Eramet - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000131757
Manganese, Nickel, Lithium, Mineral Sands, Ferronickel
Dividends
| Dividend Yield | 2.74% |
| Yield on Cost 5y | 3.30% |
| Yield CAGR 5y | -18.57% |
| Payout Consistency | 60.5% |
| Payout Ratio | 300.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 47.1% |
| Value at Risk 5%th | 69.7% |
| Relative Tail Risk | -10.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.10 |
| Alpha | 43.87 |
| CAGR/Max DD | -0.08 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.667 |
| Beta | 0.220 |
| Beta Downside | 0.476 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.54% |
| Mean DD | 38.37% |
| Median DD | 40.73% |
Description: ERA Eramet January 15, 2026
Eramet S.A. (ticker ERA) is a French-based diversified miner that extracts and processes manganese, nickel, lithium and mineral sands, supplying a broad product slate-including silicomanganese alloys, ferronickel, nickel pig iron, and zircon-based titanium dioxide-across Asia, Europe, North America and other markets. Its operating assets span the Moanda manganese mine in Gabon, nickel operations in New Caledonia and Indonesia, and a mineral-sand mine in Senegal.
As of FY 2023, Eramet reported €4.2 billion in revenue and an adjusted EBITDA margin of roughly 12 %, reflecting strong demand for stainless-steel-grade manganese and battery-grade nickel. The company’s exposure to the electric-vehicle supply chain (nickel and lithium) and to the construction-materials market (titanium-based mineral sands) are the primary economic drivers of its outlook, while Chinese stainless-steel production trends set the baseline demand for its manganese alloys.
For a deeper dive into ERA’s valuation metrics, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -127.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.23 > 0.02 and ΔFCF/TA -23.17 > 1.0 |
| NWC/Revenue: 12.53% < 20% (prev 17.17%; Δ -4.63% < -1%) |
| CFO/TA 0.02 > 3% & CFO 114.0m > Net Income -127.0m |
| Net Debt (1.88b) to EBITDA (441.0m): 4.25 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.6m) vs 12m ago -0.69% < -2% |
| Gross Margin: 45.22% > 18% (prev 0.18%; Δ 4504 % > 0.5%) |
| Asset Turnover: 95.33% > 50% (prev 104.1%; Δ -8.79% > 0%) |
| Interest Coverage Ratio: -0.39 > 6 (EBITDA TTM 441.0m / Interest Expense TTM 217.0m) |
ValueRay F-Score (Strict, 0-100) 17.96
| 1. Piotroski: 3.50pt |
| 2. FCF Yield: -34.43% |
| 3. FCF Margin: -23.27% |
| 4. Debt/Equity: 2.37 |
| 5. Debt/Ebitda: 4.25 |
| 6. ROIC - WACC: -6.14% |
| 7. RoE: -8.95% |
| 8. Revenue Trend: -54.08% |
| 9. EPS Trend: -50.61% |
What is the price of ERA shares?
As of January 22, 2026, the stock is trading at EUR 81.55 with a total of 77,695 shares traded.
Over the past week, the price has changed by -0.24%, over one month by +54.45%, over three months by +36.83% and over the past year by +46.13%.
Over the past week, the price has changed by -0.24%, over one month by +54.45%, over three months by +36.83% and over the past year by +46.13%.
Is ERA a buy, sell or hold?
Eramet has no consensus analysts rating.
What are the forecasts/targets for the ERA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59.9 | -26.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 84.2 | 3.3% |
ERA Fundamental Data Overview January 20, 2026
Market Cap USD = 2.69b (2.30b EUR * 1.1673 EUR.USD)
P/E Forward = 10.1626
P/S = 0.7906
P/B = 2.2073
Revenue TTM = 5.96b EUR
EBIT TTM = -84.0m EUR
EBITDA TTM = 441.0m EUR
Long Term Debt = 2.02b EUR (from longTermDebt, last quarter)
Short Term Debt = 406.0m EUR (from shortTermDebt, last quarter)
Debt = 2.47b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.88b EUR (from netDebt column, last quarter)
Enterprise Value = 4.03b EUR (2.30b + Debt 2.47b - CCE 746.0m)
Interest Coverage Ratio = -0.39 (Ebit TTM -84.0m / Interest Expense TTM 217.0m)
EV/FCF = -2.90x (Enterprise Value 4.03b / FCF TTM -1.39b)
FCF Yield = -34.43% (FCF TTM -1.39b / Enterprise Value 4.03b)
FCF Margin = -23.27% (FCF TTM -1.39b / Revenue TTM 5.96b)
Net Margin = -2.13% (Net Income TTM -127.0m / Revenue TTM 5.96b)
Gross Margin = 45.22% ((Revenue TTM 5.96b - Cost of Revenue TTM 3.27b) / Revenue TTM)
Gross Margin QoQ = 65.07% (prev 52.50%)
Tobins Q-Ratio = 0.66 (Enterprise Value 4.03b / Total Assets 6.15b)
Interest Expense / Debt = 3.00% (Interest Expense 74.0m / Debt 2.47b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -63.0m (EBIT -84.0m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 1.54 (Total Current Assets 2.14b / Total Current Liabilities 1.39b)
Debt / Equity = 2.37 (Debt 2.47b / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = 4.25 (Net Debt 1.88b / EBITDA 441.0m)
Debt / FCF = -1.35 (negative FCF - burning cash) (Net Debt 1.88b / FCF TTM -1.39b)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.03% (Net Income -127.0m / Total Assets 6.15b)
RoE = -8.95% (Net Income TTM -127.0m / Total Stockholder Equity 1.42b)
RoCE = -2.44% (EBIT -84.0m / Capital Employed (Equity 1.42b + L.T.Debt 2.02b))
RoIC = -1.73% (negative operating profit) (NOPAT -63.0m / Invested Capital 3.65b)
WACC = 4.41% (E(2.30b)/V(4.77b) * Re(6.73%) + D(2.47b)/V(4.77b) * Rd(3.00%) * (1-Tc(0.25)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -2.38%
Fair Price DCF = unknown (Cash Flow -1.39b)
EPS Correlation: -50.61 | EPS CAGR: -20.43% | SUE: 0.0 | # QB: 0
Revenue Correlation: -54.08 | Revenue CAGR: -12.55% | SUE: -0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=4.82 | Chg30d=+0.914 | Revisions Net=+0 | Growth EPS=+196.1% | Growth Revenue=+13.6%
P/E Forward = 10.1626
P/S = 0.7906
P/B = 2.2073
Revenue TTM = 5.96b EUR
EBIT TTM = -84.0m EUR
EBITDA TTM = 441.0m EUR
Long Term Debt = 2.02b EUR (from longTermDebt, last quarter)
Short Term Debt = 406.0m EUR (from shortTermDebt, last quarter)
Debt = 2.47b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.88b EUR (from netDebt column, last quarter)
Enterprise Value = 4.03b EUR (2.30b + Debt 2.47b - CCE 746.0m)
Interest Coverage Ratio = -0.39 (Ebit TTM -84.0m / Interest Expense TTM 217.0m)
EV/FCF = -2.90x (Enterprise Value 4.03b / FCF TTM -1.39b)
FCF Yield = -34.43% (FCF TTM -1.39b / Enterprise Value 4.03b)
FCF Margin = -23.27% (FCF TTM -1.39b / Revenue TTM 5.96b)
Net Margin = -2.13% (Net Income TTM -127.0m / Revenue TTM 5.96b)
Gross Margin = 45.22% ((Revenue TTM 5.96b - Cost of Revenue TTM 3.27b) / Revenue TTM)
Gross Margin QoQ = 65.07% (prev 52.50%)
Tobins Q-Ratio = 0.66 (Enterprise Value 4.03b / Total Assets 6.15b)
Interest Expense / Debt = 3.00% (Interest Expense 74.0m / Debt 2.47b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -63.0m (EBIT -84.0m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 1.54 (Total Current Assets 2.14b / Total Current Liabilities 1.39b)
Debt / Equity = 2.37 (Debt 2.47b / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = 4.25 (Net Debt 1.88b / EBITDA 441.0m)
Debt / FCF = -1.35 (negative FCF - burning cash) (Net Debt 1.88b / FCF TTM -1.39b)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.03% (Net Income -127.0m / Total Assets 6.15b)
RoE = -8.95% (Net Income TTM -127.0m / Total Stockholder Equity 1.42b)
RoCE = -2.44% (EBIT -84.0m / Capital Employed (Equity 1.42b + L.T.Debt 2.02b))
RoIC = -1.73% (negative operating profit) (NOPAT -63.0m / Invested Capital 3.65b)
WACC = 4.41% (E(2.30b)/V(4.77b) * Re(6.73%) + D(2.47b)/V(4.77b) * Rd(3.00%) * (1-Tc(0.25)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -2.38%
Fair Price DCF = unknown (Cash Flow -1.39b)
EPS Correlation: -50.61 | EPS CAGR: -20.43% | SUE: 0.0 | # QB: 0
Revenue Correlation: -54.08 | Revenue CAGR: -12.55% | SUE: -0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=4.82 | Chg30d=+0.914 | Revisions Net=+0 | Growth EPS=+196.1% | Growth Revenue=+13.6%